A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study
Keywords: COX-2; Cervix; VEGF; Chemoprevention; Celecoxib; CIN 3;